Na tej stronie
EHC Encompass Health Corporation Common Stock
NYSE · Health Care · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Sie 7, 2026
$119,80
· % zakresu 52 tyg.
· powyżej minimum
· do maksimum
$92,7752tyg. minimum
$127,9952tyg. maksimum
Kapitalizacja Rynkowa (MRQ)
$11.84B
P/E (TTM)
19.5
EPS (TTM)
$6.14
Przychody (TTM)
$6.21B
Twoje odznaki
Zakres 52 tyg.
$93–$128
Ocena Analityków
BUY
Cena Docelowa
$148
P/E
19.5
ROE
25.5%
Marża Zysku Netto
10.0%
Twój pasek odznak jest pusty — przypnij metrykę w dowolnym miejscu na tej stronie.
EHC Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$119.80
Kapitalizacja Rynkowa (MRQ)
$11.84B
P/E (TTM)
19.5
EPS (TTM)
$6.14
Przychody (TTM)
$6.21B
Stopa dywidendy
0.60%
ROE (TTM)
25.5%
Zakres 52 tyg.
$93–$128
EHC Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
zakres
kreski
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
Podziały akcji
| Data ex-dywidendy | Podział | Typ |
|---|---|---|
| 1 lipca 2022 | 1257-for-1000 | Naprzód |
| 26 października 2006 | 1-for-5 | Odwrotny |
| 18 marca 1997 | 2-for-1 | Naprzód |
| 18 kwietnia 1995 | 2-for-1 | Naprzód |
| 2 stycznia 1992 | 3-for-2 | Naprzód |
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody$5.94B2016-12-31 → 2025-12-31
EPS$5.542016-12-31 → 2025-12-31
Wolny przepływ pieniężny$439M2016-12-31 → 2025-12-31
Marża netto10.0%2018-12-31 → 2025-12-31
Wycena i wskaźniki
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | EHC | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | 19.5średnia z 5 lat ≈18.8 | ≈18.8 | 16.5 | Wartość godziwa | |
| P/S (TTM) | 1.9średnia z 5 lat ≈1.5 | ≈1.5 | 1.3 | Zawyżona wycena | |
| P/B (MRQ) | 4.6średnia z 5 lat ≈4.0 | ≈4.0 | 3.8 | Zawyżona wycena | |
| Cena / FCF (TTM) | 28.6średnia z 5 lat ≈29.0 | ≈29.0 | · | · | |
| Cena / Przepływy pieniężne (TTM) | 9.8średnia z 5 lat ≈8.4 | ≈8.4 | 9.7 | Niedowartościowany | |
| Cena / Wartość księgowa materialna (MRQ) | 5.2średnia z 5 lat ≈29.6 | ≈29.6 | · | · | |
| PEG Ratio (Współczynnik PEG) | ≈1.4 | · | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | EHC | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| EBITDA Margin (Marża EBITDA) | 5.5%średnia z 5 lat ≈8.0% | ≈8.0% | 11.1% | Słaby | |
| Marża przed opodatkowaniem (TTM) | 16.6%średnia z 5 lat ≈13.2% | ≈13.2% | 9.8% | Najwyższa półka | |
| Marża Zysku Netto (TTM) | 10.0%średnia z 5 lat ≈7.9% | ≈7.9% | 7.3% | Najwyższa półka | |
| ROA (TTM) | 8.7%średnia z 5 lat ≈6.4% | ≈6.4% | 6.5% | Najwyższa półka | |
| ROE (TTM) | 25.5%średnia z 5 lat ≈22.8% | ≈22.8% | 19.1% | Najwyższa półka |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | EHC | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Wskaźnik bieżący (MRQ) | 1.2średnia z 5 lat ≈1.2 | ≈1.2 | 1.2 | Zgodnie z | |
| Quick Ratio (Wskaźnik Szybkości) | 0.8średnia z 5 lat ≈0.9 | ≈0.9 | 0.9 | Zgodnie z |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | EHC | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | 10.5%średnia z 5 lat ≈10.7% | ≈10.7% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | 10.9%średnia z 5 lat ≈10.5% | ≈10.5% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 10.7% | · | · | · | |
| EPS YoY | 24.2%średnia z 5 lat ≈18.2% | ≈18.2% | · | · | |
| Net Income YoY (Zysk Netto R/R) | 24.2%średnia z 5 lat ≈18.9% | ≈18.9% | · | · | |
| EPS CAGR 3Y (CAGR z EPS 3 lata) | 27.1%średnia z 5 lat ≈12.2% | ≈12.2% | · | · | |
| EPS CAGR 5Y (CAGR z EPS 5 lat) | 14.2% | · | · | · | |
| Net Income CAGR 3Y (CAGR z zysku netto 3 lata) | 27.8%średnia z 5 lat ≈12.9% | ≈12.9% | · | · | |
| Net Income CAGR 5Y (CAGR z zysku netto 5 lat) | 14.8% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | EHC | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 0.9średnia z 5 lat ≈0.8 | ≈0.8 | 0.8 | Zgodnie z | |
| Receivables Turnover (Rotacja należności) | 9.8średnia z 5 lat ≈8.8 | ≈8.8 | 8.4 | Najwyższa półka | |
| Revenue / Employee (Przychody / pracownika) | ≈$199.8K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
Stopa Dywidendy0.60%
Wskaźnik Wypłaty Dywidendy12.6%
Zannualizowane wypłaty≈$0.76
CAGR dywidendy 5-letni≈-5.3%
Seria wzrostów≈1
| Data ex-dywidendy | Kwota | Waluta | Stopa zwrotu |
|---|---|---|---|
| Lip 1, 2026 | $0,19 | USD | ≈0.75% |
| Kwi 1, 2026 | $0,19 | USD | ≈0.76% |
| Sty 2, 2026 | $0,19 | USD | ≈0.68% |
| Paź 1, 2025 | $0,19 | USD | ≈0.56% |
| Lip 1, 2025 | $0,17 | USD | ≈0.56% |
| Kwi 1, 2025 | $0,17 | USD | ≈0.65% |
| Sty 2, 2025 | $0,17 | USD | ≈0.70% |
| Paź 1, 2024 | $0,17 | USD | ≈0.65% |
| Lip 1, 2024 | $0,15 | USD | ≈0.70% |
| Mar 28, 2024 | $0,15 | USD | ≈0.73% |
| Gru 29, 2023 | $0,15 | USD | ≈0.90% |
| Wrz 29, 2023 | $0,15 | USD | ≈0.89% |
| Cze 30, 2023 | $0,15 | USD | ≈1.3% |
| Mar 31, 2023 | $0,15 | USD | ≈1.3% |
| Gru 30, 2022 | $0,15 | USD | ≈1.3% |
| Wrz 30, 2022 | $0,15 | USD | ≈1.9% |
| Lip 12, 2022 | $0,28 | USD | ≈2.0% |
| Mar 31, 2022 | $0,22 | USD | ≈1.6% |
| Gru 31, 2021 | $0,22 | USD | ≈1.7% |
| Wrz 30, 2021 | $0,22 | USD | ≈1.5% |
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
8.6%
Następny raport
Paź 27, 2026
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Sie 3, 2026 | $1.55 | $1.49 | 3.7% |
| 31 marca 2026 | $1.60 | $1.51 | 5.8% | |
| 31 grudnia 2025 | $1.46 | $1.31 | 11.3% | |
| 30 września 2025 | $1.23 | $1.21 | 1.9% | |
| 30 czerwca 2025 | $1.40 | $1.22 | 14.6% | |
| 31 marca 2025 | $1.37 | $1.20 | 14.1% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.94B | $5.37B | $4.80B | $4.35B | $4.01B | $3.57B | $4.61B | $4.28B | $3.91B | $3.64B | |
| SG&A Expense | $236M | $209M | $202M | $154M | $170M | $152M | $247M | $220M | $172M | $133M | |
| Operating Expenses | $4.88B | $4.51B | $4.07B | $3.72B | $3.36B | $3.04B | $3.91B | $3.65B | $3.26B | $2.99B | |
| Operating Income | · | · | · | $540M | $560M | $564M | $612M | $555M | $578M | $588M | |
| Interest Expense | · | · | $144M | $176M | $164M | $184M | $160M | $147M | $154M | $172M | |
| Other Non-op | $19M | $20M | $16M | $-5M | $8M | $8M | $30M | $2M | $4M | $3M | |
| Pretax Income | $953M | $750M | $607M | $451M | $505M | $353M | $562M | $493M | $496M | $482M | |
| Income Tax | $193M | $150M | $132M | $100M | $102M | $75M | $116M | $119M | $146M | $164M | |
| Net Income | $566M | $456M | $352M | $271M | $412M | $284M | $359M | $292M | $271M | $248M | |
| EPS (Basic) | $5.62 | $4.53 | $3.51 | $2.72 | $4.15 | $2.87 | $3.65 | $2.98 | $2.88 | $2.77 | |
| EPS (Diluted) | $5.54 | $4.46 | $3.47 | $2.70 | $4.11 | $2.85 | $3.61 | $2.93 | $2.84 | $2.59 | |
| Shares (Basic) | 100,500,000 | 99,900,000 | 99,500,000 | 99,200,000 | 99,000,000 | 98,600,000 | 98,000,000 | 97,900,000 | 93,700,000 | 89,100,000 | |
| Shares (Diluted) | 102,200,000 | 102,200,000 | 101,300,000 | 100,400,000 | 100,200,000 | 99,800,000 | 99,400,000 | 99,800,000 | 99,300,000 | 99,500,000 | |
| EBITDA | $328M | $300M | $274M | $783M | $257M | $807M | $831M | $755M | $762M | $761M |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $72M | $85M | $69M | $22M | $49M | $186M | $60M | $69M | $54M | $40M | |
| Receivables | $619M | $593M | $600M | $525M | $502M | $563M | $499M | $460M | $460M | $432M | |
| Prepaid Expense | $54M | $42M | $34M | $35M | $115M | $86M | $98M | $66M | $113M | $109M | |
| Other Current Assets | $184M | $123M | $92M | $92M | $115M | $86M | $98M | $66M | $113M | $170M | |
| Current Assets | $906M | $887M | $842M | $717M | $921M | $949M | $756M | $662M | $702M | $654M | |
| PP&E (Net) | · | · | · | · | · | · | $1.96B | $1.63B | $1.52B | $1.39B | |
| PP&E (Gross) | · | · | · | · | · | · | · | $2.63B | $2.45B | $2.28B | |
| Goodwill | $1.32B | $1.28B | $1.28B | $1.26B | $1.24B | $1.23B | $1.22B | $2.10B | $1.97B | $1.93B | |
| Intangibles | $308M | $298M | $278M | $282M | $158M | $431M | $476M | $443M | $403M | $411M | |
| Other Non-current Assets | $244M | $219M | $192M | $222M | $230M | $295M | $305M | $291M | $235M | $221M | |
| Total Assets | $7.09B | $6.53B | $6.10B | $5.64B | $6.86B | $6.45B | $6.08B | $5.17B | $4.86B | $4.68B | |
| Accounts Payable | $178M | $171M | $170M | $133M | $134M | $115M | $95M | $90M | $78M | $68M | |
| Accrued Liabilities | $55M | $31M | · | · | · | · | · | · | · | · | |
| Current Liabilities | $836M | $841M | $656M | $576M | $749M | $717M | $721M | $672M | $518M | $476M | |
| Capital Leases | $197M | $190M | $196M | $200M | $180M | $210M | $244M | $0 | · | · | |
| Deferred Tax | $127M | $105M | $87M | $83M | $23M | $52M | $0 | · | · | · | |
| Other Non-current Liabilities | $207M | $52M | $46M | $46M | $49M | $94M | $43M | $86M | $75M | $50M | |
| Total Liabilities | $3.81B | $3.69B | $3.81B | $3.77B | $4.47B | $4.44B | $4.15B | $3.36B | $3.25B | $3.61B | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Paid-in Capital | $1.87B | $1.85B | $1.79B | $1.73B | $2.29B | $2.33B | $2.37B | $2.59B | $2.75B | $2.80B | |
| Retained Earnings | $1.29B | $797M | $406M | $116M | $142M | $-242M | $-526M | $-885M | $-1.18B | $-1.45B | |
| Treasury Stock | $722M | $578M | $547M | $537M | $521M | $497M | $492M | $428M | $418M | $615M | |
| AOCI | $500.0K | $0 | · | · | · | · | · | $0 | $-1M | $-1M | |
| Stockholders' Equity | $2.44B | $2.07B | $1.65B | $1.31B | $1.91B | $1.59B | $1.35B | $1.28B | $1.15B | $736M | |
| Liabilities + Equity | $7.09B | $6.53B | $6.10B | $5.64B | $6.86B | $6.45B | $6.08B | $5.17B | $4.86B | $4.68B | |
| Shares Outstanding | 100,000,000 | 100,800,000 | 100,300,000 | 99,800,000 | 99,500,000 | 99,400,000 | 98,600,000 | 98,900,000 | 98,300,000 | 88,900,000 |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $328M | $300M | $274M | $244M | $220M | $203M | $219M | $200M | $184M | $173M | |
| Stock-based Comp | $56M | $48M | $51M | $29M | $29M | $26M | $114M | $86M | $48M | $27M | |
| Deferred Tax | $22M | $11M | $4M | $28M | $17M | $34M | $40M | $-9M | $61M | $133M | |
| Amort. of Intangibles | $28M | $29M | $32M | $29M | $31M | $33M | $58M | $51M | $49M | $48M | |
| Other Non-cash | $203M | $188M | $170M | $134M | $-14M | $96M | $-96M | $194M | $94M | $25M | |
| Operating Cash Flow | $1.18B | $1.00B | $851M | $706M | $716M | $705M | $635M | $762M | $658M | $640M | |
| CapEx | $736M | $642M | $583M | $584M | $546M | $393M | $372M | $254M | $226M | $178M | |
| Investing Cash Flow | $-765M | $-653M | $-603M | $-627M | $-666M | $-408M | $-657M | $-424M | $-283M | $-230M | |
| Net Debt Issued | · | · | · | · | · | · | $-520M | $-21M | $-130M | $-202M | |
| Stock Repurchased | $158M | $31M | $0 | $0 | $0 | $6M | $46M | $0 | $38M | $66M | |
| Net Stock Activity | $-158M | $-31M | · | $0 | $0 | $-6M | $-46M | $0 | $-38M | $-66M | |
| Dividends Paid | $71M | $63M | $60M | $99M | $112M | $112M | $109M | $101M | $92M | $84M | |
| Financing Cash Flow | $-431M | $-331M | $-197M | $-146M | $-240M | $-146M | $48M | $-321M | $-360M | $-416M | |
| Net Change in Cash | $-20M | $19M | $51M | $-67M | $-191M | $151M | $26M | $17M | $15M | $-6M | |
| Taxes Paid | $124M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $439M | $360M | $268M | $141M | $187M | $309M | $263M | $508M | $431M | $428M | |
| Levered FCF | · | · | $155M | $4M | $57M | $165M | $136M | $396M | $327M | $314M |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | 12.4% | · | 12.1% | 13.3% | 13.0% | · | · | |
| Net Margin | 9.5% | 8.5% | 7.3% | 6.2% | 8.1% | 6.1% | 7.8% | 6.8% | · | · | |
| Pretax Margin | 16.1% | 14.0% | 12.7% | 10.4% | 12.8% | 10.2% | 12.2% | 11.5% | · | · | |
| EBITDA Margin | 5.5% | 5.6% | 5.7% | 18.0% | 5.0% | 17.4% | 18.0% | 17.6% | · | · | |
| ROA | 8.3% | 7.2% | 6.0% | 4.3% | 6.2% | 4.5% | 6.4% | 5.8% | 5.3% | 5.3% | |
| ROE | 25.1% | 24.5% | 23.8% | 16.8% | 23.6% | 19.3% | 27.3% | 24.1% | 26.7% | 36.8% | |
| ROIC | · | · | · | 32.0% | · | 27.7% | 35.9% | 33.0% | 33.1% | 52.7% |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.1 | 1.3 | 1.2 | 1.2 | 1.3 | 1.0 | 1.0 | 1.4 | 1.4 | |
| Quick Ratio | 0.8 | 0.8 | 1.0 | 0.9 | 1.0 | 1.1 | 0.8 | 0.8 | 1.0 | 1.0 | |
| Interest Coverage | · | · | · | 3.1 | · | 3.1 | 3.8 | 3.8 | 3.7 | 3.4 |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.9 | 0.9 | 0.8 | 0.7 | 0.8 | 0.7 | 0.8 | 0.9 | · | · | |
| Receivables Turnover | 9.8 | 9.0 | 8.5 | 8.5 | 8.3 | 8.7 | 9.6 | 9.3 | · | · |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $24.38 | $20.51 | $16.43 | $13.13 | $19.21 | $15.98 | $13.71 | $12.91 | $12.02 | $8.28 | |
| Revenue / Share | $58.07 | $52.58 | $47.40 | $43.31 | $51.11 | $46.54 | $46.33 | $42.86 | · | · | |
| Cash Flow / Share | $11.50 | $9.81 | $8.40 | $7.03 | $7.14 | $7.06 | $6.39 | $7.64 | $6.62 | $6.09 | |
| Cash / Share | $0.72 | $0.85 | $0.69 | $0.22 | $0.55 | $2.25 | $0.96 | $0.70 | $0.55 | $0.46 | |
| Dividend / Share | $0.72 | $0.64 | $0.60 | $0.86 | $1.12 | $1.12 | $1.10 | $1.04 | $0.98 | $0.94 | |
| EPS (TTM) | $5.54 | $4.46 | $3.47 | $2.70 | $4.11 | $2.85 | $3.61 | $2.93 | $2.84 | $2.59 |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.5% | 11.9% | 10.4% | 8.3% | 12.6% | · | · | · | · | · | |
| Revenue CAGR 3Y | 10.9% | 10.2% | 10.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.7% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 24.2% | 28.5% | 28.5% | -34.3% | 44.2% | · | · | · | · | · | |
| EPS CAGR 3Y | 27.1% | 2.8% | 6.8% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 14.2% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 24.2% | 29.5% | 29.9% | -34.3% | 45.0% | · | · | · | · | · | |
| Net Income CAGR 3Y | 27.8% | 3.4% | 7.4% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 14.8% | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | -8.6% | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5.94B | $5.37B | $4.80B | $4.35B | $4.01B | $3.57B | $4.61B | $4.28B | $3.91B | $3.64B | |
| Net Income TTM | $566M | $456M | $352M | $271M | $412M | $284M | $359M | $292M | $271M | $248M | |
| Market Cap | $10.61B | $9.31B | $6.69B | $5.97B | $5.17B | $6.54B | $5.43B | $4.85B | $3.86B | $2.92B | |
| P/E | 19.2 | 20.7 | 19.2 | 22.2 | 12.6 | 23.1 | 15.3 | 16.8 | 13.8 | 12.7 | |
| P/S | 1.8 | 1.7 | 1.4 | 1.4 | 1.3 | 1.8 | 1.2 | 1.1 | 1.0 | 0.8 | |
| P/B | 4.4 | 4.5 | 4.1 | 4.6 | 2.7 | 4.1 | 4.0 | 3.8 | 3.3 | 4.0 | |
| P / Tangible Book | 13.1 | 19.2 | 76.0 | · | 10.0 | · | · | · | · | · | |
| P / Cash Flow | 9.0 | 9.3 | 7.9 | 8.5 | 7.2 | 9.3 | 8.6 | 6.4 | 5.9 | 4.8 | |
| P / FCF | 24.2 | 25.8 | 25.0 | 42.3 | 27.6 | 21.2 | 20.7 | 9.6 | 9.0 | 6.8 | |
| Dividend Yield | 0.67% | 0.67% | 0.90% | 1.7% | 2.2% | 1.7% | 2.0% | 2.1% | 2.4% | 2.9% | |
| Earnings Yield | 5.2% | 4.8% | 5.2% | 4.5% | 7.9% | 4.3% | 6.6% | 6.0% | 7.2% | 7.9% | |
| Payout Ratio | 12.6% | 13.8% | 17.2% | 36.5% | 27.3% | 39.4% | 30.3% | 34.5% | 35.7% | 33.8% | |
| Annual Payout | $71M | $63M | $60M | $99M | $112M | $112M | $109M | $101M | $92M | $84M |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.60B | $1.59B | $1.54B | $1.48B | $1.46B | $1.46B | $1.41B | $1.35B | $1.30B | $1.32B | $1.25B | $1.21B | $1.19B | $1.16B | $1.14B | $1.09B | |
| SG&A Expense | $63M | $58M | $68M | $56M | $59M | $52M | $54M | $54M | $50M | $50M | $53M | $50M | $55M | $43M | $43M | $38M | |
| Operating Expenses | $1.31B | $1.28B | $1.26B | $1.23B | $1.20B | $1.19B | $1.17B | $1.14B | $1.09B | $1.11B | $1.06B | $1.03B | $1.00B | $982M | $958M | $941M | |
| Operating Income | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $152M | $128M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $35M | · | $36M | $36M | $36M | · | $38M | |
| Other Non-op | $9M | $19M | $4M | $6M | $7M | $2M | $2M | $9M | $3M | $5M | $9M | $500.0K | $3M | $4M | $8M | $-4M | |
| Pretax Income | $262M | $289M | $258M | $220M | $237M | $239M | $201M | $184M | $186M | $178M | $165M | $145M | $151M | $146M | $151M | $107M | |
| Income Tax | $54M | $56M | $55M | $45M | $51M | $42M | $38M | $36M | $38M | $38M | $37M | $30M | $33M | $32M | $32M | $22M | |
| Net Income | $154M | $194M | $146M | $126M | $142M | $152M | $121M | $108M | $114M | $112M | $88M | $85M | $91M | $88M | $89M | $45M | |
| EPS (Basic) | $1.55 | $1.96 | $1.45 | $1.26 | $1.41 | $1.50 | $1.20 | $1.08 | $1.13 | $1.12 | $0.87 | $0.85 | $0.91 | $0.88 | $0.90 | $0.45 | |
| EPS (Diluted) | $1.54 | $1.93 | $1.43 | $1.24 | $1.39 | $1.48 | $1.18 | $1.06 | $1.12 | $1.10 | $0.86 | $0.84 | $0.90 | $0.87 | $0.89 | $0.45 | |
| Shares (Basic) | 98,800,000 | 99,200,000 | · | 100,500,000 | 100,600,000 | 100,500,000 | · | 99,900,000 | 99,900,000 | 99,800,000 | · | 99,500,000 | 99,500,000 | 99,400,000 | · | 99,200,000 | |
| Shares (Diluted) | 100,000,000 | 100,600,000 | · | 102,300,000 | 102,300,000 | 102,100,000 | · | 102,100,000 | 102,000,000 | 102,200,000 | · | 101,400,000 | 101,100,000 | 100,900,000 | · | 100,500,000 | |
| EBITDA | $90M | $87M | · | $82M | $80M | $79M | · | $78M | $73M | $70M | · | $67M | $73M | $64M | · | $62M |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $108M | $110M | $72M | $49M | $99M | $96M | $85M | $148M | $154M | $134M | $69M | $100M | $118M | $85M | $22M | $60M | |
| Receivables | $687M | $676M | $613M | $611M | $612M | $623M | $593M | $576M | $590M | $619M | · | $536M | $532M | $514M | · | $500M | |
| Prepaid Expense | · | · | $54M | · | · | · | $42M | · | · | · | · | · | · | · | · | · | |
| Other Current Assets | $220M | $190M | $130M | $165M | $168M | $165M | $123M | $159M | $166M | $138M | · | $137M | $138M | $128M | · | $130M | |
| Current Assets | $1.04B | $1.03B | $906M | $870M | $918M | $911M | $887M | $934M | $938M | $930M | · | $814M | $824M | $762M | · | $734M | |
| Goodwill | $1.32B | $1.32B | $1.32B | $1.30B | $1.30B | $1.28B | $1.28B | $1.28B | $1.28B | $1.28B | $1.28B | $1.28B | $1.27B | $1.27B | $1.26B | $1.25B | |
| Intangibles | $307M | $300M | $308M | $292M | $296M | $294M | $298M | $296M | $303M | $272M | · | $276M | $278M | $287M | · | $285M | |
| Other Non-current Assets | $246M | $244M | $244M | $257M | $233M | $210M | $219M | $211M | $208M | $179M | · | $210M | $220M | $227M | · | $207M | |
| Total Assets | $7.46B | $7.31B | $7.09B | $6.87B | $6.79B | $6.64B | $6.53B | $6.46B | $6.39B | $6.23B | · | $5.96B | $5.86B | $5.75B | · | $5.48B | |
| Accounts Payable | $222M | $204M | $178M | $138M | $174M | $159M | $171M | $170M | $164M | $166M | · | $165M | $156M | $141M | · | $134M | |
| Accrued Liabilities | · | · | $55M | · | · | · | $31M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $873M | $877M | $836M | $762M | $865M | $856M | $841M | $897M | $694M | $680M | · | $639M | $655M | $592M | · | $605M | |
| Capital Leases | $181M | $189M | $197M | $203M | $201M | $204M | $190M | $196M | $202M | $186M | · | $184M | $192M | $199M | · | $183M | |
| Deferred Tax | $132M | $135M | $127M | $108M | $111M | $114M | $105M | $97M | $91M | $94M | · | $80M | $83M | $87M | · | $47M | |
| Other Non-current Liabilities | $212M | $214M | $54M | $213M | $201M | $196M | $52M | $198M | $187M | $186M | · | $179M | $176M | $183M | · | $174M | |
| Total Liabilities | $4.00B | $3.95B | $3.81B | $3.68B | $3.70B | $3.70B | $3.69B | $3.73B | $3.86B | $3.83B | · | $3.78B | $3.80B | $3.78B | · | $3.73B | |
| Common Stock | · | · | $1M | · | · | · | $1M | · | · | · | · | · | · | · | · | · | |
| Paid-in Capital | · | · | $1.87B | · | · | · | $1.85B | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | · | · | $1.29B | · | · | · | $797M | · | · | · | · | · | · | · | · | · | |
| Treasury Stock | · | · | $722M | · | · | · | $578M | · | · | · | · | · | · | · | · | · | |
| AOCI | · | · | $500.0K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $2.60B | $2.52B | $2.44B | $2.37B | $2.28B | $2.16B | $2.07B | $1.96B | $1.84B | $1.74B | · | $1.56B | $1.48B | $1.38B | · | $1.22B | |
| Liabilities + Equity | $7.46B | $7.31B | $7.09B | $6.87B | $6.79B | $6.64B | $6.53B | $6.46B | $6.39B | $6.23B | · | $5.96B | $5.86B | $5.75B | · | $5.48B | |
| Shares Outstanding | 98,800,000 | 99,400,000 | 100,000,000 | 100,700,000 | 100,900,000 | 100,900,000 | 100,800,000 | 100,800,000 | 100,700,000 | 100,700,000 | 100,300,000 | 100,200,000 | 100,200,000 | 100,200,000 | 99,800,000 | 99,800,000 |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $90M | $87M | $86M | $82M | $80M | $79M | $78M | $78M | $73M | $70M | $70M | $67M | $73M | $64M | $63M | $62M | |
| Stock-based Comp | $14M | $12M | $18M | $14M | $14M | $10M | $12M | $13M | $14M | $9M | $13M | $14M | $16M | $8M | $8M | $5M | |
| Deferred Tax | $-3M | $8M | $19M | $-2M | $-4M | $9M | $9M | $-2M | $-2M | $6M | $7M | $-3M | $-4M | $4M | $36M | $200.0K | |
| Other Non-cash | · | $11M | · | · | · | $40M | · | · | · | $40M | · | · | · | $64M | · | · | |
| Operating Cash Flow | $283M | $313M | $346M | $271M | $270M | $289M | $279M | $268M | $217M | $239M | $201M | $215M | $207M | $228M | $172M | $70M | |
| CapEx | $220M | $162M | $229M | $187M | $157M | $163M | $199M | $148M | $157M | $139M | $212M | $158M | $125M | $100M | $209M | $145M | |
| Investing Cash Flow | $-236M | $-150M | $-239M | $-201M | $-165M | $-158M | $-204M | $-162M | $-158M | $-130M | $-208M | $-162M | $-128M | $-104M | $-206M | $-174M | |
| Stock Repurchased | $74M | $72M | $76M | $25M | $25M | $32M | $8M | $7M | $17M | $0 | $0 | $0 | · | · | · | · | |
| Net Stock Activity | · | $-72M | · | · | · | $-32M | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid | $19M | $20M | $19M | $17M | $17M | $18M | $17M | $15M | $15M | $16M | $15M | $15M | $15M | $16M | $15M | $28M | |
| Financing Cash Flow | $-77M | $-102M | $-97M | $-113M | $-90M | $-130M | $-151M | $-90M | $-50M | $-41M | $-30M | $-66M | $-44M | $-58M | $-16M | $-49M | |
| Net Change in Cash | $-30M | $60M | $9M | $-44M | $15M | $-300.0K | $-76M | $17M | $9M | $68M | $-37M | $-13M | $35M | $66M | $-51M | $-153M | |
| Free Cash Flow | · | $151M | · | · | · | $126M | · | · | · | $99M | · | · | · | $131M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $72M | · | · | · | $103M | · | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 9.6% | 12.3% | · | 8.6% | 9.8% | 10.4% | · | 8.0% | 8.8% | 8.6% | · | 7.1% | 7.7% | 7.6% | · | 4.2% | |
| Pretax Margin | 16.4% | 18.2% | · | 14.9% | 16.2% | 16.4% | · | 13.6% | 14.3% | 13.6% | · | 12.0% | 12.7% | 12.6% | · | 9.8% | |
| EBITDA Margin | 5.7% | 5.5% | · | 5.6% | 5.5% | 5.4% | · | 5.8% | 5.6% | 5.3% | · | 5.6% | 6.1% | 5.5% | · | 5.7% | |
| ROA | 2.2% | 2.8% | · | 1.9% | 2.2% | 2.4% | · | 1.7% | 1.9% | 1.9% | · | 1.5% | 1.4% | 1.4% | · | 0.74% | |
| ROE | 6.3% | 8.3% | · | 5.8% | 6.9% | 7.8% | · | 6.2% | 6.9% | 7.2% | · | 6.1% | 5.3% | 5.2% | · | 3.0% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 1.2 | · | 1.1 | 1.1 | 1.1 | · | 1.0 | 1.4 | 1.4 | · | 1.3 | 1.3 | 1.3 | · | 1.2 | |
| Quick Ratio | 0.9 | 0.9 | · | 0.9 | 0.8 | 0.8 | · | 0.8 | 1.1 | 1.1 | · | 1.0 | 1.0 | 1.0 | · | 0.9 |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 2.5 | 2.4 | · | 2.5 | 2.4 | 2.3 | · | 2.4 | 2.3 | 2.3 | · | 2.3 | 2.0 | 1.9 | · | 1.9 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $26.29 | $25.37 | · | $23.57 | $22.60 | $21.40 | · | $19.44 | $18.27 | $17.30 | · | $15.57 | $14.72 | $13.81 | · | $12.19 | |
| Revenue / Share | $15.97 | $15.77 | · | $14.44 | $14.25 | $14.25 | · | $13.23 | $12.76 | $12.88 | · | $11.90 | $11.74 | $11.50 | · | $10.84 | |
| Cash Flow / Share | · | $3.11 | · | · | · | $2.83 | · | · | · | $2.34 | · | · | · | $2.26 | · | · | |
| Cash / Share | $1.09 | $1.11 | · | $0.48 | $0.98 | $0.95 | · | $1.47 | $1.53 | $1.33 | · | $0.99 | $1.17 | $0.85 | · | $0.60 | |
| Dividend / Share | $0.19 | $0.19 | $0.19 | $0.19 | $0.17 | $0.17 | $0.17 | $0.17 | $0.15 | $0.15 | $0.15 | $0.15 | $0.15 | $0.15 | $0.15 | $0.15 | |
| EPS (TTM) | $6.14 | $5.99 | · | $5.29 | $5.11 | $4.84 | · | $4.14 | $3.92 | $3.70 | · | $3.50 | $3.11 | $2.70 | · | $2.72 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6.21B | $6.07B | · | $5.80B | $5.67B | $5.51B | · | $5.21B | $5.07B | $4.96B | · | $4.69B | $4.57B | $4.45B | · | $3.70B | |
| Net Income TTM | $621M | $609M | · | $541M | $523M | $495M | · | $422M | $400M | $377M | · | $354M | $314M | $271M | · | $273M | |
| Market Cap | $9.99B | $9.61B | · | $12.79B | $12.37B | $10.22B | · | $9.74B | $8.64B | $8.32B | · | $6.73B | $6.78B | $5.42B | · | $4.51B | |
| P/E | 16.5 | 16.1 | · | 24.0 | 24.0 | 20.9 | · | 23.3 | 21.9 | 22.3 | · | 19.2 | 21.8 | 20.0 | · | 16.6 | |
| P/S | 1.6 | 1.6 | · | 2.2 | 2.2 | 1.9 | · | 1.9 | 1.7 | 1.7 | · | 1.4 | 1.5 | 1.2 | · | 1.2 | |
| P/B | 3.8 | 3.8 | · | 5.4 | 5.4 | 4.7 | · | 5.0 | 4.7 | 4.8 | · | 4.3 | 4.6 | 3.9 | · | 3.7 | |
| P / Tangible Book | 10.3 | 10.6 | · | 16.4 | 18.2 | 17.6 | · | 25.7 | 34.2 | 44.1 | · | 2492.4 | · | · | · | · | |
| P / Cash Flow | · | 30.7 | · | · | · | 35.4 | · | · | · | 34.8 | · | · | · | 23.8 | · | · | |
| Dividend Yield | 0.75% | 0.76% | · | 0.54% | 0.54% | 0.64% | · | 0.62% | 0.70% | 0.73% | · | 0.90% | 1.1% | 1.6% | · | 2.5% | |
| Earnings Yield | 6.1% | 6.2% | · | 4.2% | 4.2% | 4.8% | · | 4.3% | 4.6% | 4.5% | · | 5.2% | 4.6% | 5.0% | · | 6.0% | |
| Payout Ratio | · | 10.4% | · | · | · | 11.9% | · | · | · | 14.1% | · | · | · | 17.8% | · | · | |
| Annual Payout | $75M | $73M | · | $69M | $67M | $65M | · | $61M | $61M | $61M | · | $60M | $73M | $86M | · | $112M |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $5.94B | $5.37B | $4.80B | $4.35B | $4.01B |
| Marża Operacyjna % | · | · | · | 12.4% | · |
| Zysk netto | $566M | $456M | $352M | $271M | $412M |
| Rozwodniony EPS | $5.54 | $4.46 | $3.47 | $2.70 | $4.11 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 1.1 | 1.1 | 1.3 | 1.2 | 1.2 |
| Wskaźnik Szybkości | 0.8 | 0.8 | 1.0 | 0.9 | 1.0 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $439M | $360M | $268M | $141M | $187M |
Właściciele instytucjonalni (13F) 645 emitentów · $10.0B łącznie · Na dzień 30 września 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Posiadacze
645
Wartość posiadanych akcji
$10.0B
Nowe pozycje
72
Zamknięte pozycje
37
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 72 (-13 vs poprzedni kw.) | 37 (-42 vs poprzedni kw.) | 220 (-10 vs poprzedni kw.) | 219 (+32 vs poprzedni kw.) | +2.0M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $1 075 201 277 | 10 130 029 | 10,79% | Akcje |
| BlackRock, Inc. | $1 059 761 675 | 10 484 385 | 10,63% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $497 785 037 | 4 924 664 | 4,99% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $452 423 568 | 4 475 896 | 4,54% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $331 414 937 | 3 278 739 | 3,33% | Akcje |
| STATE STREET CORP | $322 020 462 | 3 185 798 | 3,23% | Akcje |
| CITADEL ADVISORS LLC | $259 078 552 | 2 563 104 | 2,60% | Akcje |
| FULLER & THALER ASSET MANAGEMENT, INC. | $248 723 177 | 2 460 657 | 2,50% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $239 092 474 | 2 471 751 | 2,40% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $229 215 881 | 2 267 668 | 2,30% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $191 163 529 | 1 890 743 | 1,92% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $176 185 032 | 1 743 028 | 1,77% | Akcje |
| GOLDMAN SACHS GROUP INC | $156 754 618 | 1 550 797 | 1,57% | Akcje |
| Invesco Ltd. | $117 364 796 | 1 161 108 | 1,18% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $116 942 484 | 1 156 930 | 1,17% | Akcje |
| NORGES BANK | $116 733 653 | 1 154 864 | 1,17% | Akcje |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $116 351 672 | 1 151 085 | 1,17% | Akcje |
| MORGAN STANLEY | $115 926 200 | 1 146 873 | 1,16% | Akcje |
| JPMORGAN CHASE & CO | $114 840 512 | 1 133 561 | 1,15% | Akcje |
| RAYMOND JAMES FINANCIAL INC | $107 572 603 | 1 064 233 | 1,08% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $106 181 901 | 1 050 470 | 1,07% | Akcje |
| Eversept Partners, LP | $103 800 973 | 1 026 919 | 1,04% | Akcje |
| BROWN ADVISORY INC | $102 366 881 | 1 012 731 | 1,03% | Akcje |
| Holocene Advisors, LP | $98 819 245 | 977 634 | 0,99% | Akcje |
| NORTHERN TRUST CORP | $98 116 739 | 970 684 | 0,98% | Akcje |
| Sumitomo Mitsui Trust Group, Inc. | $94 037 756 | 930 330 | 0,94% | Akcje |
| Capital Research Global Investors | $88 196 343 | 872 540 | 0,88% | Akcje |
| Copeland Capital Management, LLC | $86 465 426 | 855 415 | 0,87% | Akcje |
| Bank of New York Mellon Corp | $81 676 122 | 808 034 | 0,82% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $81 441 874 | 805 717 | 0,82% | Akcje |
| BANK OF AMERICA CORP /DE/ | $79 660 158 | 788 090 | 0,80% | Akcje |
| Allianz Asset Management GmbH | $70 954 117 | 701 960 | 0,71% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $69 569 725 | 688 264 | 0,70% | Akcje |
| AMERIPRISE FINANCIAL INC | $64 412 004 | 637 218 | 0,65% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $63 453 374 | 627 754 | 0,64% | Akcje |
| JENNISON ASSOCIATES LLC | $61 331 503 | 606 762 | 0,62% | Akcje |
| FRANKLIN RESOURCES INC | $60 494 863 | 598 485 | 0,61% | Akcje |
| JANE STREET GROUP, LLC | $58 888 804 | 582 596 | 0,59% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $56 576 495 | 561 888 | 0,57% | Akcje |
| Qube Research & Technologies Ltd | $56 391 016 | 557 885 | 0,57% | Akcje |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $55 475 233 | 548 825 | 0,56% | Akcje |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $44 796 000 | 443 177 | 0,45% | Akcje |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | $44 792 698 | 443 140 | 0,45% | Akcje |
| REINHART PARTNERS, LLC. | $44 008 230 | 435 362 | 0,44% | Akcje |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $43 276 391 | 428 140 | 0,43% | Akcje |
| SEI INVESTMENTS CO | $41 745 070 | 412 994 | 0,42% | Akcje |
| CONGRESS ASSET MANAGEMENT CO | $41 050 742 | 406 121 | 0,41% | Akcje |
| VICTORY CAPITAL MANAGEMENT INC | $39 864 840 | 394 389 | 0,40% | Akcje |
| D. E. Shaw & Co., Inc. | $38 874 863 | 384 595 | 0,39% | Akcje |
| Freestone Grove Partners LP | $38 677 251 | 382 640 | 0,39% | Akcje |
Aktywiści i właściciele 5%+ 2 akcje
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| East Peak Partners, L.P., JGE Capital Management, LLC, Jeffrey G. Edwards ×2 zgłoszenia | 10 czerwca 2008 | · | Pierwotne zgłoszenie | · | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 12 maja 2005 | · | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insiderzy spółki 51 insiderów · 20 dyrektorzy generalni · 25 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| April Kaye Bullock Anthony | CEO & President, Home Health | 18 czerwca 2021 D | 175 269 | 0 | 0 | $0 |
| Jay Grinney | Pres & Chief Executive Officer | 31 grudnia 2016 D | 1 231 767 | 0 | 0 | $0 |
| Diane L Munson | President, OP Services | 31 lipca 2007 D | 5 772 | 0 | 0 | $0 |
| Joseph T Clark | President, Surgery Division | 30 czerwca 2007 D | 1 569 | 0 | 0 | $0 |
| Gregory R Brophy | President, Diagnostic Division | 2 marca 2007 A | 12 000 | 0 | 0 | $0 |
| Keren G Davis | President, Diagnostic Division | 23 lutego 2006 A | 30 898 | 0 | 0 | $0 |
| Patrick A Foster | President and COO Inpatient | 20 maja 2004 F | 83 150 | 0 | 0 | $0 |
| Larry D Taylor | President and COO, Surgery | 5 marca 2004 A | 73 700 | 0 | 0 | $0 |
| Patrick William Tuer | EVP, Chief Operating Officer | 11 maja 2026 S | 24 755 | 0 | 2 | $-373 076 |
| Michael D Snow | Chief Operating Officer | 30 czerwca 2007 D | 17 548 | 0 | 0 | $0 |
| John Patrick Darby | EVP, Gen Counsel & Secretary | 31 sierpnia 2026 M | 75 041 | 0 | 2 | $-1 709 966 |
| Andrew L Price | Chief Accounting Officer | 31 sierpnia 2026 S | 69 483 | 0 | 1 | $-630 166 |
| Edmund Fay | Sr. Vice Pres. and Treasurer | 9 marca 2026 G | 86 325 | 0 | 1 | $-1 277 259 |
| Elissa Joy Charbonneau | Chief Medical Officer | 28 lutego 2026 F | 17 644 | 0 | 0 | $0 |
| Cheryl B. Levy | Chief Human Resources Officer | 25 lutego 2019 F | 41 732 | 0 | 0 | $0 |
| John P Whittington | EVP, Gen. Counsel & Secretary | 18 lutego 2016 A | 202 094 | 0 | 0 | $0 |
| Dexanne B Clohan | Chief Medical Officer | 31 lipca 2015 M | 109 120 | 0 | 0 | $0 |
| John F Markus | Chief Compliance Officer | 4 sierpnia 2007 D | 5 942 | 0 | 0 | $0 |
| Gregory L Doody | Exec VP Legal and Secretary | 31 lipca 2006 D | 0 | 0 | 0 | $0 |
| James C Foxworthy | Chief Administrative Officer | 23 lutego 2006 A | 144 418 | 0 | 0 | $0 |
| Edward M Christie III | Dyrektor | 16 lipca 2026 A | 9 345 | 0 | 0 | $0 |
| Christopher R Reidy | Dyrektor | 16 lipca 2026 A | 17 777 | 0 | 0 | $0 |
| Cain A Hayes | Dyrektor | 15 lipca 2026 A | 2 096 | 0 | 0 | $0 |
| Kevin J. O'Connor | Dyrektor | 15 lipca 2026 A | 11 582 | 0 | 0 | $0 |
| Terrance Williams | Dyrektor | 15 lipca 2026 A | 16 859 | 0 | 0 | $0 |
| Nancy M Schlichting | Dyrektor | 15 lipca 2026 A | 22 972 | 0 | 0 | $0 |
| Joan E Herman | Dyrektor | 15 lipca 2026 A | 49 643 | 0 | 0 | $0 |
| Greg D Carmichael | Dyrektor | 15 lipca 2026 A | 20 349 | 0 | 0 | $0 |
| Leslye G Katz | Dyrektor | 15 lipca 2026 A | 49 643 | 0 | 0 | $0 |
| Patricia Anne Maryland | Dyrektor | 15 lipca 2025 A | 14 764 | 0 | 0 | $0 |
| John Chidsey | Dyrektor | 16 kwietnia 2024 A | 162 826 | 0 | 0 | $0 |
| Donald L Correll | Dyrektor | 15 kwietnia 2024 A | 99 938 | 0 | 0 | $0 |
| John E Jr D D S Maupin | Dyrektor | 19 kwietnia 2022 A | 81 262 | 0 | 0 | $0 |
| Edward L Shaw JR | Dyrektor | 19 kwietnia 2022 A | 99 385 | 0 | 0 | $0 |
| Yvonne M Curl | Dyrektor | 18 kwietnia 2022 A | 78 458 | 0 | 0 | $0 |
| Charles M Elson | Dyrektor | 18 kwietnia 2022 A | 82 981 | 0 | 0 | $0 |
| HIGDON LEO I JR | Dyrektor | 18 kwietnia 2022 A | 5 104 | 0 | 0 | $0 |
| Jon F Hanson | Dyrektor | 16 kwietnia 2014 A | 88 770 | 0 | 0 | $0 |
| Edward A Blechschmidt | Dyrektor | 11 kwietnia 2012 J | 52 844 | 0 | 0 | $0 |
| BERRARD STEVEN R | Dyrektor | 18 maja 2006 D | 24 973 | 0 | 0 | $0 |
| Robert P May | Dyrektor | 20 października 2005 D | 23 531 | 0 | 0 | $0 |
| George H Strong | Dyrektor | 29 stycznia 2004 P | 89 217 | 0 | 0 | $0 |
| John S Chamberlin | Dyrektor | 20 stycznia 2004 A | 140 432 | 0 | 0 | $0 |
| Larry D Striplin JR | Dyrektor | 20 stycznia 2004 A | 73 432 | 0 | 0 | $0 |
| Mark J Tarr | · | 10 sierpnia 2026 S | 267 814 | 0 | 9 | $-38 470 785 |
| Douglas E Coltharp | · | 10 sierpnia 2026 S | 50 508 | 0 | 3 | $-5 324 345 |
| Barbara Ann Jacobsmeyer | · | 1 marca 2022 A | 59 539 | 0 | 0 | $0 |
| John L Workman | · | 17 listopada 2009 D | 72 716 | 0 | 0 | $0 |
| Joel C Gordon | · | 10 maja 2005 D | 1 348 023 | 0 | 0 | $0 |
| Lee S Hillman | · | 18 lutego 2005 D | 2 024 | 0 | 0 | $0 |
| Sage C Givens | · | 20 stycznia 2004 A | 41 432 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 75 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| OSCV · ETF Series Solutions | 2,13% | 135 598 NS | 31 lipca 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,86% | 175 295 NS | 31 lipca 2026 | N-PORT |
| IHF · iShares Trust | 1,76% | 190 583 SH | 11 września 2026 | Dziennie |
| GRPM · Invesco Exchange-Traded Fund Trust | 1,40% | 58 485 SH | 2 października 2026 | Dziennie |
| XMLV · Invesco Exchange-Traded Fund Trust … | 1,03% | 59 385 SH | 2 października 2026 | Dziennie |
| HSMV · First Trust Exchange-Traded Fund III | 1,02% | 3 221 NS | 31 lipca 2026 | N-PORT |
| SMDX · Tidal Trust III | 0,69% | 8 093 NS | 31 lipca 2026 | N-PORT |
| CZA · Invesco Exchange-Traded Fund Trust | 0,61% | 10 363 SH | 2 października 2026 | Dziennie |
| RFG · Invesco Exchange-Traded Fund Trust | 0,58% | 16 279 SH | 2 października 2026 | Dziennie |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,52% | 97 881 SH | 19 sierpnia 2026 | Dziennie |
| QLV · FlexShares Trust | 0,49% | 7 224 NS | 31 lipca 2026 | N-PORT |
| VFMV · VANGUARD WELLINGTON FUND | 0,46% | 18 863 SH | 19 sierpnia 2026 | Dziennie |
| IQSM · New York Life Investments ETF Trust | 0,42% | 12 521 NS | 31 lipca 2026 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,38% | 13 067 SH | 2 października 2026 | Dziennie |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,35% | 18 161 NS | 31 lipca 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,33% | 13 621 NS | 31 lipca 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0,31% | 10 882 NS | 31 lipca 2026 | N-PORT |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,27% | 160 356 SH | 19 sierpnia 2026 | Dziennie |
| BKMC · BNY Mellon ETF Trust | 0,26% | 15 377 NS | 31 lipca 2026 | N-PORT |
| ESML · iShares Trust | 0,25% | 58 197 SH | 11 września 2026 | Dziennie |
| RWK · Invesco Exchange-Traded Fund Trust … | 0,25% | 26 726 SH | 2 października 2026 | Dziennie |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,24% | 9 827 NS | 31 lipca 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,24% | 43 342 NS | 31 lipca 2026 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0,24% | 1 456 NS | 31 lipca 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,23% | 52 547 NS | 31 lipca 2026 | N-PORT |
| ISCG · iShares Trust | 0,22% | 17 302 SH | 11 września 2026 | Dziennie |
| VBR · VANGUARD INDEX FUNDS | 0,21% | 1 444 357 SH | 19 sierpnia 2026 | Dziennie |
| IYH · iShares Trust | 0,19% | 57 739 SH | 11 września 2026 | Dziennie |
| SMMD · iShares Trust | 0,17% | 52 551 SH | 11 września 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,16% | 226 407 NS | 31 lipca 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,16% | 47 198 NS | 31 lipca 2026 | N-PORT |
| NFRA · FlexShares Trust | 0,15% | 41 445 NS | 31 lipca 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,15% | 298 871 SH | 19 sierpnia 2026 | Dziennie |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,14% | 10 513 NS | 31 lipca 2026 | N-PORT |
| ESUM · Strategy Shares | 0,14% | 2 294 NS | 31 lipca 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0,12% | 2 275 030 SH | 19 sierpnia 2026 | Dziennie |
| IWS · iShares Trust | 0,12% | 147 557 SH | 11 września 2026 | Dziennie |
| FTLS · First Trust Exchange-Traded Fund III | 0,12% | 25 879 NS | 31 lipca 2026 | N-PORT |
| WSML · iShares Trust | 0,11% | 6 185 SH | 11 września 2026 | Dziennie |
| VXF · VANGUARD INDEX FUNDS | 0,11% | 1 138 311 SH | 19 sierpnia 2026 | Dziennie |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,10% | 5 455 NS | 31 lipca 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 6 245 SH | 2 października 2026 | Dziennie |
| IWR · iShares Trust | 0,09% | 404 246 SH | 11 września 2026 | Dziennie |
| DXUV · Dimensional ETF Trust | 0,08% | 4 083 NS | 31 lipca 2026 | N-PORT |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,08% | 10 190 NS | 31 lipca 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,06% | 82 039 NS | 31 lipca 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,05% | 213 642 NS | 31 lipca 2026 | N-PORT |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0,04% | 9 905 NS | 31 lipca 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,04% | 12 046 NS | 31 lipca 2026 | N-PORT |
| IUSG · iShares Trust | 0,03% | 87 340 SH | 11 września 2026 | Dziennie |
| IWD · iShares Trust | 0,03% | 218 350 SH | 11 września 2026 | Dziennie |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,03% | 2 526 SH | 2 października 2026 | Dziennie |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 59 361 SH | 19 sierpnia 2026 | Dziennie |
| DFAU · Dimensional ETF Trust | 0,02% | 25 298 NS | 31 lipca 2026 | N-PORT |
| ESGV · VANGUARD WORLD FUND | 0,02% | 22 240 SH | 19 sierpnia 2026 | Dziennie |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,02% | 7 822 SH | 2 października 2026 | Dziennie |
| TILT · FlexShares Trust | 0,02% | 3 402 NS | 31 lipca 2026 | N-PORT |
| IYY · iShares Trust | 0,02% | 4 296 SH | 10 września 2026 | Dziennie |
| IWB · iShares Trust | 0,02% | 68 163 SH | 11 września 2026 | Dziennie |
| IWV · iShares Trust | 0,02% | 27 979 SH | 10 września 2026 | Dziennie |
| DFUS · Dimensional ETF Trust | 0,02% | 31 574 NS | 31 lipca 2026 | N-PORT |
| ITOT · iShares Trust | 0,02% | 130 529 SH | 11 września 2026 | Dziennie |
| PRF · Invesco Exchange-Traded Fund Trust | 0,02% | 13 574 SH | 2 października 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 3 151 418 SH | 19 sierpnia 2026 | Dziennie |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 78 793 SH | 19 sierpnia 2026 | Dziennie |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,01% | 16 144 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 8 257 SH | 19 sierpnia 2026 | Dziennie |
| NEAR · iShares U.S. ETF Trust | 0,00% | 83 000 SH | 9 września 2026 | Dziennie |
| IJH · iShares Trust | · | 3 481 076 SH | 11 września 2026 | Dziennie |
| IJK · iShares Trust | · | 574 423 SH | 11 września 2026 | Dziennie |
| XJH · iShares Trust | · | 13 552 SH | 8 września 2026 | Dziennie |
| ISCB · iShares Trust | · | 4 462 SH | 11 września 2026 | Dziennie |
| ISCV · iShares Trust | · | 9 814 SH | 11 września 2026 | Dziennie |
| SMLF · iShares Trust | · | 41 132 SH | 11 września 2026 | Dziennie |
| SMMV · iShares Trust | · | 19 246 SH | 26 sierpnia 2026 | Dziennie |
EHC Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
ocena · 18 analityków
KUP
Średni cel
$150.00
+25,2%
7 38,9%
Mocne kupno
10 55,6%
Kup
1 5,6%
Trzymaj
0 0,0%
Sprzedaj
0 0,0%
Mocna sprzedaż
12-miesięczny cel cenowy
12 analityków · 2026-09-27Średnia cel $148.17 +23,7%
← Poniżej wszystkich celów
Aktualna cena $119.80
Niski$140.00
Średnia$148.17
Wysoki$155.00
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| EHC | $10.61B | 19.2 | 10.5% | 9.5% | 25.1% | · |
| HCA | $104.86B | 16.5 | 7.1% | 9.0% | -159.1% | · |
| THC | $17.28B | 12.8 | 3.1% | 11.1% | 56.4% | · |
| UHS | · | 9.4 | 9.7% | 8.6% | 21.4% | · |
| ENSG | $10.12B | 29.8 | 18.7% | 6.8% | 16.9% | · |
| PACS | $6.01B | 31.5 | 29.3% | 3.6% | 23.1% | · |
| CON | $2.53B | 15.1 | 13.9% | 7.7% | 49.8% | · |
| BKD | $2.57B | -9.6 | 2.2% | -8.2% | -313.2% | 26.2% |
| ACHC | $1.28B | -1.2 | 5.0% | -33.3% | -43.9% | · |
| SNDA | $612M | -7.7 | 25.2% | -18.6% | -197.2% | · |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Źródło: SEC 10-Q złożone Sie 7, 2026